All Cancer articles – Page 38
-
NewsPharma giant strikes deal to save breast cancer drug funding
The Swiss drug giant Novartis has struck a deal with NHS England to prevent one of its breast cancer treatments being axed from the cancer drugs fund.
-
NewsExclusive: NHS England drug delay led to ‘absolutely preventable’ deaths
A two year delay in NHS England drawing up a prescribing policy for a licensed drug has led to at least two ‘absolutely preventable’ deaths and more than 30 adults and children left at significant risk, HSJ has been told.
-
NewsCancer drugs spared funding axe following appeals
Three drugs that NHS England said would be axed from the cancer drugs fund will remain available at least temporarily, following a series of appeals by drug companies.
-
HSJ LocalLocal care networks model favoured by CCG
STRUCTURE: Lewisham Clinical Commissioning Group is one of six CCGs in south east London pursuing joint plans for a ‘whole system model’ of healthcare implemented by ‘local care networks’ in each borough.
-
News'Pioneering' cancer care buddying scheme launched
A new scheme has been launched to ‘buddy’ trusts struggling to deliver a good care experience to cancer patients with higher performing trusts.
-
HSJ LocalCancer patients miss out on surgery due to winter pressures
PERFORMANCE: Elective surgery in “many specialties” - including cancer – has been postponed or cancelled in Leeds because of excess demand for services over winter.
-
SupplementsRoundtable: What more people living longer with cancer means for the NHS
Taking the long view on cancer care
-
CommentCommissioners must help defuse England’s cancer time bomb
Tackling the looming cancer challenge
-
HSJ LocalLeicester Hospitals adopts automated drugs system
COMMERCIAL: University Hospitals of Leicester Trust is to adopt a hi-tech medicines management system which will use robots to pack individual drug doses.
-
HSJ LocalNHS consortium challenges NHS England £80m contract decision
A consortium of NHS trusts have lodged a formal challenge against NHS England following its decision to hand a 10 year, £80m contract for PET CT scanning to a private company.
-
NewsNHS England delays access to NICE approved drug
Patients will be put at risk of developing cancer after NHS England was granted permission to delay access to a groundbreaking cure for hepatitis C, patient groups have warned.
-
NewsCancer drugs fund will need to cut more treatments, chair warns
Treatments available through the cancer drugs fund will have to continue being cut, the NHS England official in charge of the fund has said.
-
NewsCancer drugs fund receives surprise £60m boost
NHS England has announced a surprise £60m boost to the cancer drugs fund, bringing it up to £340m for 2015-16, even as it slashes the number of drugs available.
-
HSJ LocalTrust hopes for £6m income from new cancer unit
FINANCE: A West Midlands acute trust is hoping to generate £5.9m in extra income per year following the opening of a new £23m cancer treatment unit this month.
-
HSJ LocalClatterbridge to reconfigure cancer care after ‘resounding’ public support
STRUCTURE: A specialist cancer trust in Merseyside is pressing ahead with plans to build a new centre in Liverpool.
-
HSJ LocalNo evidence of 'systematic manipulation' of Colchester cancer data
There is no evidence of staff being told to manipulate cancer waiting times data at Colchester Hospital University Foundation Trust, an independent investigation commissioned by Monitor has found.
-
NewsAppeal finds NICE decision on £90k breast cancer drug 'unfair'
The impact of the government’s drug pricing deal on patient access to new medicines has been thrown into confusion after a pharmaceutical company’s appeal against the decision to ban routine NHS funding of one of its drugs was upheld.
-
-
-
HSJ LocalWhistleblowing review of cancer trust finds no evidence of 'serious failings'
WORKFORCE: A review into whistleblowing concerns at a North West cancer trust has found “no evidence” of serious failings but highlighted areas in need of improvement.